Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs10492070 | chr12:5108943 | A/G | 3.08E-5 | 178 | 25.4 | 24.23 | 14.4 | KM Plot |
PCPG | rs10493183 | chr1:56333648 | T/C | 2.01E-7 | 174 | 25.7 | 25.67 | 13.27 | KM Plot |
PCPG | rs10493185 | chr1:56321789 | A/G | 2.13E-7 | 173 | 25.87 | 20.02 | 15.6 | KM Plot |
PCPG | rs10493187 | chr1:56320969 | C/T | 0.000119 | 178 | 25.87 | 17.4 | 22.52 | KM Plot |
PCPG | rs10502873 | chr18:44141951 | C/T | 1.22E-7 | 176 | 25.08 | 26.57 | 19.87 | KM Plot |
PCPG | rs10508205 | chr10:1081747 | C/G | 1.28E-5 | 176 | 24.62 | 28.58 | 13.38 | KM Plot |
PCPG | rs10509292 | chr10:69726087 | A/C | 0 | 178 | 25.87 | 18.2 | 2.28 | KM Plot |
PCPG | rs10509293 | chr10:69805786 | G/A | 0 | 177 | 25.87 | 18.2 | 2.28 | KM Plot |
PCPG | rs10514996 | chr17:50285434 | G/A | 3.59E-5 | 177 | 25.53 | 28.3 | 14.43 | KM Plot |
PCPG | rs10514998 | chr17:50299809 | A/G | 5.9E-5 | 178 | 25.4 | 28.38 | 14.47 | KM Plot |
PCPG | rs10515923 | chr2:118579145 | G/A | 1.95E-5 | 176 | 25.28 | 28.45 | 11.65 | KM Plot |
PCPG | rs10520130 | chr15:39753842 | C/T | 0.000433 | 177 | 24.85 | 27.27 | 26.33 | KM Plot |
PCPG | rs1056123 | chr2:24338428 | T/G | 0.000114 | 177 | 25.4 | 26.92 | 17.43 | KM Plot |
PCPG | rs10607038 | chr6:123124297 | AGTG/A | 3.53E-6 | 177 | 8.67 | 27.27 | 24.85 | KM Plot |
PCPG | rs1060855 | chr4:110971890 | G/C | 0 | 176 | 26.88 | 18.2 | 2.93 | KM Plot |